Ever Supreme Bio Technology Co., Ltd (TPEX:6712)

TPEX:6712 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	301.68	336.44	353.57	641.1	68.88
Short-Term Investments	636.5	998.6	915.99	702.6	346.1
Cash & Short-Term Investments	938.18	1,335	1,270	1,344	414.98
Cash Growth	-29.73%	5.16%	-5.52%	223.80%	-30.15%
Accounts Receivable	193.99	100.63	84.94	33.66	15.4
Other Receivables	7.56	0.46	0.88	29.6	2.24
Receivables	201.54	101.09	85.82	63.27	17.63
Inventory	80.04	69.09	88.3	56.77	35.49
Prepaid Expenses	3.44	7.92	6.29	2.11	10.46
Other Current Assets	0.06	7.73	5.46	0.92	0.07
Total Current Assets	1,223	1,521	1,455	1,467	478.63
Property, Plant & Equipment	48.58	64.81	89.84	125.01	171.24
Long-Term Investments	796.16	471.31	376.37	333.27	112.51
Other Intangible Assets	10.15	10.65	11.95	11.14	9.9
Long-Term Deferred Tax Assets	10.73	1.71	30.32	78.2	80.56
Other Long-Term Assets	47.24	6.57	9.72	8.22	5.48
Total Assets	2,136	2,076	1,974	2,023	858.32
Accounts Payable	25.13	23.33	29.08	15	5.04
Accrued Expenses	2.4	1.96	3.98	10.49	3.62
Current Portion of Leases	1.71	5.4	4.5	11.87	9.87
Current Income Taxes Payable	68.07	46.76	10.47	21.04	-
Current Unearned Revenue	194.13	121.65	89.89	12.22	4.12
Other Current Liabilities	37.66	32.55	25.82	25.9	17.67
Total Current Liabilities	329.09	231.64	163.74	96.51	40.32
Long-Term Leases	1.14	0.5	13.36	22.55	33.34
Long-Term Deferred Tax Liabilities	10.82	-	3.59	3.82	0.05
Other Long-Term Liabilities	0.78	0.82	0.76	1.96	3.86
Total Liabilities	341.82	232.96	181.45	124.83	77.56
Common Stock	806.73	733.39	681.4	618.18	562.89
Additional Paid-In Capital	551.72	785.91	872.22	1,211	486.55
Retained Earnings	434.23	323.67	238.51	68.74	-300.86
Comprehensive Income & Other	1.6	-	0.04	-	32.19
Shareholders' Equity	1,794	1,843	1,792	1,898	780.76
Total Liabilities & Equity	2,136	2,076	1,974	2,023	858.32
Total Debt	2.84	5.9	17.86	34.42	43.21
Net Cash (Debt)	935.33	1,329	1,252	1,309	371.77
Net Cash Growth	-29.63%	6.19%	-4.40%	252.17%	-33.40%
Net Cash Per Share	11.59	16.19	15.10	15.81	4.98
Filing Date Shares Outstanding	80.67	80.67	82.42	82.25	74.9
Total Common Shares Outstanding	80.67	80.67	82.42	82.25	74.9
Working Capital	894.16	1,289	1,292	1,370	438.31
Book Value Per Share	22.24	22.84	21.74	23.07	10.42
Tangible Book Value	1,784	1,832	1,780	1,887	770.86
Tangible Book Value Per Share	22.12	22.71	21.60	22.94	10.29
Machinery	93.5	91.2	85.39	82.64	104.52
Leasehold Improvements	63.28	65.23	65.23	63.9	63.64

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.